KIMMTRAK 100mcg/0.5ml concentrate for solution for infusion IMMUNOCORE IRELAND L ORIGINAL MEDICINE
Chemical substance: tebentafusp
ATC code: L01XX75 • Antineoplastic and immunomodulating agents | Other antineoplastic agents
Active substance
Results for the substance tebentafusp
1 result
About this active substance
Tebentafusp is an immunotherapeutic agent used for the treatment of metastatic uveal melanoma. It is a bispecific antibody that binds T cells to tumor cells, activating the immune system to destroy cancer cells.
The medication is administered via intravenous infusion, as directed by a doctor. It is important for patients to be closely monitored during treatment to prevent severe adverse reactions.
Patients should be aware of potential side effects, such as infusion site reactions, fever, or flu-like symptoms. It is important to inform the doctor of any unusual symptoms.
Common side effects include fever, chills, nausea, and fatigue. In rare cases, severe reactions such as cytokine release syndrome or serious allergic reactions may occur. Patients should be informed of these risks before starting treatment.
The medication is administered via intravenous infusion, as directed by a doctor. It is important for patients to be closely monitored during treatment to prevent severe adverse reactions.
Patients should be aware of potential side effects, such as infusion site reactions, fever, or flu-like symptoms. It is important to inform the doctor of any unusual symptoms.
Common side effects include fever, chills, nausea, and fatigue. In rare cases, severe reactions such as cytokine release syndrome or serious allergic reactions may occur. Patients should be informed of these risks before starting treatment.